Celyad SA Financials

Celyad SA Stock Summary

Celyad SA competes with Innate Pharma, Addex Therapeutics, Aptorum Group, Dyadic International, and Pmv Pharmaceuticals. Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.

Celyad SA Key Financial Ratios

Celyad Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Celyad SA's current stock value. Our valuation model uses many indicators to compare Celyad SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celyad SA competition to find correlations between indicators driving Celyad SA's intrinsic value. More Info.Celyad SA is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Celyad SA by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Celyad SA Market Pulse

Along with financial statement analysis, the daily predictive indicators of Celyad SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Celyad SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Celyad SA based on widely used predictive technical indicators. In general, we focus on analyzing Celyad Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Celyad SA's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.